Promising progress for new treatment of type 1 diabetes

30 julio 2015

New research shows promising progress in the use of anti-inflammatory cytokine for treatment of type 1 diabetes. The study reveals that administration of interleukin-35 (a protein made by immune cells) to mice with type 1 diabetes, reverses or cures the disease by maintaining a normal blood glucose level and the immune tolerance.img src=»» height=»1″ width=»1″ alt=»»/